The Treat FTD Fund
Backs clinical trials for frontotemporal degeneration with milestone-based funding and expert oversight.
About
The Treat FTD Fund supports clinical trials for frontotemporal degeneration through a joint ADDF-AFTD route. It sits at the clinical end of ADDF's FTD work and is built for teams that are already past early discovery and into patient-facing development.
The program uses grant funding, runs annually, and is open globally to for-profit companies, nonprofits, universities, and research organizations…
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.